Bausch Health Companies (BHC) Receivables - Other (2016)
Bausch Health Companies (BHC) posted Receivables - Other of $60.0 million for Q4 2016.
Bausch Health Companies (BHC) Receivables - Other (2016) Analysis & Trends
Bausch Health Companies has reported Receivables - Other for 1 years, with the latest figure at $60.0 million in Q4 2016.
- Quarterly Receivables - Other changed N/A year-over-year to $60.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $60.0 million (changed N/A YoY) and the FY2016 annual result came in at $60.0 million, changed N/A from the prior year.
- Receivables - Other held at $60.0 million in Q4 2016 per BHC's latest filing.
- Over five years, Receivables - Other peaked at $60.0 million in Q4 2016 and troughed at $60.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 60.00 Mn |
| Dec 31, 2016 | 60.00 Mn |